Can fructosamine be a surrogate for HbA1c in evaluating the achievement of therapeutic goals in diabetes?

Diabetes and Metabolism

Volumn 27, Issue 5 I, 2001, Pages 598-603

  Narbonne, H ^a   Renacco, E ^a   Pradel, V ^a   Portugal, H ^a   Vialettes, B ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Blood glucose control; Fructosamine; Glycated haemoglobin

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSAMINE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PATIENT CODING; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 0035149963     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Correlation of glucose regulation and hemoglobin Alc in diabetes mellitus
2. Standardization of glycohemoglobin determinations in the clinical laboratory: Three years of experience
3. Kinetics of HbA1c. Glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
4. Glycated hemoglobin: Methodologies and clinical applications
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
7. Dosage de l'hèmoglobine A 1c et hèmoglobinopathies: Problémes posès et conduite à tenir
8. 1c
9. Marqueurs de la glycation des protéines dans le dépistage du diabète. Application aux populations à forte prévalence d'hémoglobinopathies
10. 1c determination in patients with hemoglobinopathies
11. Glycosylation of serum albumin: Elevated glycosyl-albumin in diabetes patients
12. Non-enzymatically glycosylated serum protein in diabetes mellitus: An index of short-term glycaemia
13. Glycosylated serum albumin: An intermediate index of diabetic control
14. Nonenzymatic glucosylation of rat albumin: Studies in vitro and in vivo
15. Serum fructosamine concentration in patients with nephrotic syndrome and with cirrhosis of the liver: The influence of hypoalbuminaemia and hypergammaglobulinaemia
16. Hemoglobin A1 and serum fructosamine levels in hyperthyroidism
17. The effect of altered thyroid function on serum fructosamine concentrations
18. 1c in non-diabetic pregnant women
19. Report of the expert committee on the diagnosis and classification of diabetes mellitus
20. Statistical methods for accessing agreement between two methods of clinical measurement
21. Fructosamine cannot replace HbA1c in the management of type 2 diabetes (NIDDM)
22. 1c
23. Comparison of the real-time use of glycosylated haemoglobin and plasma fructosamine in the diabetic clinic
24. Comparison of serum fructosamine vs glycohemoglobin as mesures of glycemic control in a large diabetic population
25. 1c in a adult population
26. Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes
27. Value of fasting blood glucose and serum fructosamine as a mesure of diabetic control in non-insulin-dependent diabetes mellitus
28. Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in yong adults with insulin-dependent diabetes
29. Effect of aspirin on determinations of glycosylated hemoglobin
30. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay